Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors

Is there a preferred regimen? [5]

Research output: Contribution to journalArticle

28 Citations (Scopus)
Original languageEnglish
Pages (from-to)2597-2598
Number of pages2
JournalJournal of Clinical Oncology
Volume24
Issue number16
DOIs
StatePublished - Jun 1 2006

Fingerprint

Drug Administration Schedule
Antineoplastic Combined Chemotherapy Protocols
Germ Cell and Embryonal Neoplasms
Bleomycin
Etoposide
Cisplatin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{5c77d46fa97a43788fd53557a0dccb7b,
title = "Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: Is there a preferred regimen? [5]",
author = "Lawrence Einhorn and Richard Foster",
year = "2006",
month = "6",
day = "1",
doi = "10.1200/JCO.2006.05.6184",
language = "English",
volume = "24",
pages = "2597--2598",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "16",

}

TY - JOUR

T1 - Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors

T2 - Is there a preferred regimen? [5]

AU - Einhorn, Lawrence

AU - Foster, Richard

PY - 2006/6/1

Y1 - 2006/6/1

UR - http://www.scopus.com/inward/record.url?scp=33744973343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744973343&partnerID=8YFLogxK

U2 - 10.1200/JCO.2006.05.6184

DO - 10.1200/JCO.2006.05.6184

M3 - Article

VL - 24

SP - 2597

EP - 2598

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 16

ER -